Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
Objective: Promotion of the proliferative expansion of CD4+Foxp3+ regulatory T cells (Tregs) is one of the side effects that limits the use of bleomycin (BLM) in the treatment of tumors. In this study, we examined the hypothesis that cyclophosphamide (CY), a chemotherapeutic agent with the capacity...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
China Anti-Cancer Association
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0afc7b65b64c49c7b4d5bfdf3c71892c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|